Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human...
- Mechanism
- Curator reviewed
Problems with the limited availability of human hepatocytes for cell transplantation may be overcome by efficient cryopreservation techniques and formation of appropriate cell banking. Clinicians in academic settings have found that, following administration, human hepatocytes engraft and create new functioning liver tissue, which may provide a bridge to transplant or in some cases, eliminate the need for a liver transplant.
- Primary indication
- Investigated for use/treatment in liver disease.Curator reviewed
What you can answer from here — as of April 02, 2025
Which companies are running trials of cryopreserved human liver cells, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account